Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association's Get With The Guidelines Registry.
J Racial Ethn Health Disparities
cards; cards publication; oregon; portland; covid-19; diversity
As COVID-19 cases begin to decrease in the USA, learning from the pandemic experience will provide insights regarding disparities of care delivery. We sought to determine if specific populations hospitalized with COVID-19 are equally likely to be enrolled in clinical trials. We examined patients hospitalized with COVID-19 at centers participating in the American Heart Association's COVID-19 CVD Registry. The primary outcome was odds of enrollment in a clinical trial, according to sex, race, and ethnicity. Among 14,397 adults hospitalized with COVID-19, 9.5% (n = 1,377) were enrolled in a clinical trial. The proportion of enrolled patients was the lowest for Black patients (8%); in multivariable analysis, female and Black patients were less likely to be enrolled in a clinical trial related to COVID-19 compared to men and other racial groups, respectively. Determination of specific reasons for the disparities in trial participation related to COVID-19 in these populations should be further investigated.
Shah, Kevin S; Reyes-Miranda, Adriana E; Bradley, Steven M; Breathett, Khadijah; Das, Sandeep R; Gluckman, Tyler J; Gupta, Divya; Leung, Daniel T; Mutharasan, R Kannan; Peterson, Pamela N; Spivak, Emily S; and Shah, Rashmee U, "Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association's Get With The Guidelines Registry." (2022). Articles, Abstracts, and Reports. 5880.